...
首页> 外文期刊>Asia-Pacific Biotech News >Chinese Medicine and Cancer Treatment in Hong Kong: A General Review
【24h】

Chinese Medicine and Cancer Treatment in Hong Kong: A General Review

机译:香港的中医药与癌症治疗:综述

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cancer is a pathological condition. Removal of the cancer is a necessity in the treatment process. However, removal has reached its limitations as the cancer could, in the first place, be too extensive, or, in spite of the removal, recurrence still occurs. When the pathological process is not stopped, no matter how effective is the cancer removal, the formation of cancer is going to be repeated. Cancer treatment has therefore gone beyond the stage of cancer removal and other approaches such as controlling the blood supply, initiating apoptosis. and regulating the responsible genes, are considered important. The treatment approach needs to be modified from a single target, eliminative direction towards a multiple target, holistic direction. Chinese medicine lacks a perfect understanding of the causative pathology, hence it follows a multi-target holistic approach. As new systems of cancer treatment are not yet mature, using Chinese medicine as an adjuvant therapy could be an innovative and practical investment, to bring about better results of cancer control.
机译:癌症是一种病理状况。去除癌症是治疗过程中的必要条件。然而,切除已达到其局限性,因为癌症首先可能过于广泛,或者尽管切除,但仍会复发。当病理过程没有停止时,无论癌症清除的效果如何,癌症的形成都将重复。因此,癌症治疗已经超出了癌症清除和其他方法的阶段,例如控制血液供应,启动细胞凋亡。和调节负责任的基因被认为很重要。需要将治疗方法从单一目标的消除方向变为多个目标的整体方向。中医对病因病理学缺乏完全的了解,因此它遵循多目标整体方法。由于新的癌症治疗系统尚未成熟,因此使用中药作为辅助疗法可能是一项创新且实用的投资,以带来更好的癌症控制效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号